T26	Exp 146 148	we
T27	Exp 189 194	which
T28	Exp 459 471	the presence
T29	Exp 650 654	When
T30	Exp 701 713	the presence
T31	Exp 848 860	the presence
T32	Exp 944 948	when
T33	Exp 935 943	the case
T34	Exp 998 1010	the presence
T35	Exp 1070 1074	when
T36	Exp 1168 1172	when
T37	Exp 1075 1092	the pre-treatment
T38	Exp 1159 1167	the case
T39	Exp 1447 1459	the presence
T40	Exp 1487 1513	the pre-culture conditions
T41	Exp 1517 1525	the PBMC
T42	Exp 1562 1566	that
T43	Exp 1567 1598	the IL-10-induced up-regulation
T44	Exp 1633 1647	the prevention
T45	Exp 1686 1708	the whole blood assays
T46	Exp 1539 1552	these results
T47	Exp 1756 1779	the adherence parameter
T48	Exp 1797 1825	the IL-10-induced modulation
R2	Coref Anaphora:T27 Antecedent:T49
T1	Protein 31 36	IL-10
T2	Protein 62 67	IL-10
T3	Protein 195 200	IL-10
T4	Protein 256 277	tumor necrosis factor
T5	Protein 279 282	TNF
T6	Protein 493 498	IL-10
T7	Protein 535 538	TNF
T8	Protein 574 577	TNF
T9	Protein 591 595	IL-6
T10	Protein 612 618	IL-1ra
T11	Protein 717 722	IL-10
T12	Protein 772 777	IL-10
T13	Protein 871 879	IL-1beta
T14	Protein 904 907	TNF
T15	Protein 1014 1019	IL-10
T16	Protein 1106 1111	IL-10
T17	Protein 1202 1207	IL-10
T18	Protein 1297 1302	IL-10
T19	Protein 1384 1388	CD16
T20	Protein 1393 1397	CD68
T21	Protein 1417 1421	CD14
T22	Protein 1463 1468	IL-10
T23	Protein 1571 1576	IL-10
T24	Protein 1801 1806	IL-10
T49	Exp 165 185	experimental studies
